“When we started looking at pharmacogenetics a few years ago, it was cutting-edge technology. I think more and more we are starting to see this as a standard of care,” said Dr. Joel Diamond.
Aranscia‘s Dr. Joel Diamond spoke with HIMSS TV to discuss the progression of precision medicine since his last interview at HIMSS 2022 and how molecular diagnostics is working to improve patient outcomes.
Click here to watch “Digital Checkup with Andrea Fox featuring Joel Diamond, MD, CMO at Aranscia.”
